Israel Englander Relay Therapeutics, Inc. Call Options Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
Call Options
2 transactions
Others Institutions Holding RLAY
# of Institutions
214Shares Held
173MCall Options Held
0Put Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$113 Million0.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct13.4MShares$54.6 Million0.1% of portfolio
-
Commodore Capital LP New York, NY13.4MShares$54.2 Million4.31% of portfolio
-
Casdin Capital, LLC New York, NY11.4MShares$46.3 Million5.53% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$42.8 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $488M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...